Parents of kids with type 2 diabetes will be relieved to know that two additional drugs have just received FDA approval for children over the age of 10. Newly Approved Diabetes Drugs The US Food and Drug Administration (FDA) announced in June 2023, the approval of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) for type 2 […]

The post Jardiance and Synjardy Approved for Kids Aged Ten and Up appeared first on Medical News Bulletin.

Moorfields Eye Hospital London experts, led by Pearse Keane, have developed an Artificial Intelligence tool to provide a fast and reliable diagnosis for patients with eye-related diseases.  In recent years, there has been a rapid push to integrate artificial intelligence (AI) into healthcare systems. Artificial Intelligence (AI) serves to train a machine to make precise, swift, […]

The post Keeping an AI on Retinopathy appeared first on Medical News Bulletin.

Good news for men living with an enlarged prostate: clinicians have developed a novel way to treat Benign Prostate Hyperplasia (BPH) without sacrificing sexual function. On June 30, 2023, the FDA announced its approval of Optilume BPH for the treatment of an enlarged prostate. “The next-generation Optilume BPH Catheter System offers a safe and effective new, […]

The post Benign Prostate Hyperplasia: New Device Preserves Sexual Function appeared first on Medical News Bulletin.

The U.S. Food and Drug Administration (FDA) has expanded approval of QULIPTA® (atogepant) for use in preventative treatment of chronic migraine.1  In a press release from manufacturer AbbVie, Chief Medical Officer, Roopal Thakkar, explains, “Since September 2021, QULIPTA has helped people living with episodic migraine prevent migraine attacks, reducing the daily burden of migraine. Now, […]

The post FDA Approves Preventative Pill for Chronic Migraine appeared first on Medical News Bulletin.

Could the use of acetaminophen lead to risk-taking behaviour? Emotional reactions to different stimuli can influence risk perception and, thus, risky behaviours. Acetaminophen, the medicinal ingredient in Tylenol® and many other pharmaceuticals is commonly used to relieve pain and fever. One of acetaminophen’s side effects may be influencing risk-taking behaviour by altering emotional responses.1 The […]

The post Acetaminophen’s Effect on Risk-Taking Behaviour appeared first on Medical News Bulletin.

Treatments for open-angle glaucoma are needed. Glaucoma is a leading cause of irreversible blindness, which can be terrifying and significantly affect someone’s quality of life. Unfortunately, this disease is estimated to have damaged the eyesight of over 70 million people worldwide.1 Also, 10% of people who experience blindness in both eyes cannot see as a […]

The post Treatments for Open-Angle Glaucoma appeared first on Medical News Bulletin.

Ulcerative colitis (UC), an inflammatory bowel disease, is a debilitating condition with no known cause or cure. The Sishen pill is a therapeutic modality derived from traditional Chinese medicine (TCM) that relieves UC issues.1 Uncertainty continues on the mechanisms of how the Sishen pill works to improve ulcerative colitis. Understanding the basics of ulcerative colitis […]

The post Sishen Pill Treatment for Ulcerative Colitis appeared first on Medical News Bulletin.

Improved health and well-being are at the forefront of mindfulness meditation benefits. With this practice continuously gaining traction, researchers wanted to perform a clinical trial for evidence of its efficacy in improving cognitive function (attention, memory, processing speed, and executive functioning). Mindfulness training appears attractive for those looking to strengthen skills and improve health, but […]

The post Mindfulness Meditation Debunked? appeared first on Medical News Bulletin.